List of Tables
Table 1. EGFR Inhibitor Market Trends
Table 2. EGFR Inhibitor Market Drivers & Opportunity
Table 3. EGFR Inhibitor Market Challenges
Table 4. EGFR Inhibitor Market Restraints
Table 5. Global EGFR Inhibitor Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global EGFR Inhibitor Revenue Market Share by Company (2019-2024)
Table 7. Global EGFR Inhibitor Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global EGFR Inhibitor Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market EGFR Inhibitor Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers EGFR Inhibitor Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers EGFR Inhibitor Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of EGFR Inhibitor
Table 13. Global EGFR Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in EGFR Inhibitor as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global EGFR Inhibitor Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global EGFR Inhibitor Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global EGFR Inhibitor Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global EGFR Inhibitor Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global EGFR Inhibitor Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global EGFR Inhibitor Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global EGFR Inhibitor Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global EGFR Inhibitor Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global EGFR Inhibitor Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global EGFR Inhibitor Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global EGFR Inhibitor Price by Type (2019-2024) & (US$/Unit)
Table 27. Global EGFR Inhibitor Price by Type (2025-2030) & (US$/Unit)
Table 28. Global EGFR Inhibitor Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global EGFR Inhibitor Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global EGFR Inhibitor Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global EGFR Inhibitor Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global EGFR Inhibitor Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global EGFR Inhibitor Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global EGFR Inhibitor Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global EGFR Inhibitor Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global EGFR Inhibitor Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global EGFR Inhibitor Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global EGFR Inhibitor Price by Application (2019-2024) & (US$/Unit)
Table 39. Global EGFR Inhibitor Price by Application (2025-2030) & (US$/Unit)
Table 40. Global EGFR Inhibitor Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global EGFR Inhibitor Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global EGFR Inhibitor Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global EGFR Inhibitor Sales Value by Region (2019-2024) & (%)
Table 44. Global EGFR Inhibitor Sales Value by Region (2025-2030) & (%)
Table 45. Global EGFR Inhibitor Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global EGFR Inhibitor Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global EGFR Inhibitor Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global EGFR Inhibitor Sales Volume by Region (2019-2024) & (%)
Table 49. Global EGFR Inhibitor Sales Volume by Region (2025-2030) & (%)
Table 50. Global EGFR Inhibitor Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global EGFR Inhibitor Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions EGFR Inhibitor Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions EGFR Inhibitor Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions EGFR Inhibitor Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions EGFR Inhibitor Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions EGFR Inhibitor Sales Volume, (2025-2030) & (K Units)
Table 57. AstraZeneca Company Information
Table 58. AstraZeneca Introduction and Business Overview
Table 59. AstraZeneca EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. AstraZeneca EGFR Inhibitor Product Offerings
Table 61. AstraZeneca Recent Development
Table 62. Roche Company Information
Table 63. Roche Introduction and Business Overview
Table 64. Roche EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Roche EGFR Inhibitor Product Offerings
Table 66. Roche Recent Development
Table 67. Boehringer-Ingelheim Company Information
Table 68. Boehringer-Ingelheim Introduction and Business Overview
Table 69. Boehringer-Ingelheim EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Boehringer-Ingelheim EGFR Inhibitor Product Offerings
Table 71. Boehringer-Ingelheim Recent Development
Table 72. Pfizer Company Information
Table 73. Pfizer Introduction and Business Overview
Table 74. Pfizer EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Pfizer EGFR Inhibitor Product Offerings
Table 76. Pfizer Recent Development
Table 77. Mylan Company Information
Table 78. Mylan Introduction and Business Overview
Table 79. Mylan EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Mylan EGFR Inhibitor Product Offerings
Table 81. Mylan Recent Development
Table 82. Genvio Pharma Company Information
Table 83. Genvio Pharma Introduction and Business Overview
Table 84. Genvio Pharma EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Genvio Pharma EGFR Inhibitor Product Offerings
Table 86. Genvio Pharma Recent Development
Table 87. Alice Company Information
Table 88. Alice Introduction and Business Overview
Table 89. Alice EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Alice EGFR Inhibitor Product Offerings
Table 91. Alice Recent Development
Table 92. Teva Pharmaceuticals Company Information
Table 93. Teva Pharmaceuticals Introduction and Business Overview
Table 94. Teva Pharmaceuticals EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Teva Pharmaceuticals EGFR Inhibitor Product Offerings
Table 96. Teva Pharmaceuticals Recent Development
Table 97. Blueprint Medicines Company Information
Table 98. Blueprint Medicines Introduction and Business Overview
Table 99. Blueprint Medicines EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Blueprint Medicines EGFR Inhibitor Product Offerings
Table 101. Blueprint Medicines Recent Development
Table 102. Biotherapeutics Company Information
Table 103. Biotherapeutics Introduction and Business Overview
Table 104. Biotherapeutics EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Biotherapeutics EGFR Inhibitor Product Offerings
Table 106. Biotherapeutics Recent Development
Table 107. Junshi Biosciences Company Information
Table 108. Junshi Biosciences Introduction and Business Overview
Table 109. Junshi Biosciences EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. Junshi Biosciences EGFR Inhibitor Product Offerings
Table 111. Junshi Biosciences Recent Development
Table 112. Cttq Company Information
Table 113. Cttq Introduction and Business Overview
Table 114. Cttq EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. Cttq EGFR Inhibitor Product Offerings
Table 116. Cttq Recent Development
Table 117. Betta Pharmaceuticals Company Information
Table 118. Betta Pharmaceuticals Introduction and Business Overview
Table 119. Betta Pharmaceuticals EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Betta Pharmaceuticals EGFR Inhibitor Product Offerings
Table 121. Betta Pharmaceuticals Recent Development
Table 122. Qilu Pharmaceutical Company Information
Table 123. Qilu Pharmaceutical Introduction and Business Overview
Table 124. Qilu Pharmaceutical EGFR Inhibitor Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Qilu Pharmaceutical EGFR Inhibitor Product Offerings
Table 126. Qilu Pharmaceutical Recent Development
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. EGFR Inhibitor Downstream Customers
Table 130. EGFR Inhibitor Distributors List
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. EGFR Inhibitor Product Picture
Figure 2. Global EGFR Inhibitor Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global EGFR Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 4. Global EGFR Inhibitor Sales Volume (2019-2030) & (K Units)
Figure 5. Global EGFR Inhibitor Sales Price (2019-2030) & (US$/Unit)
Figure 6. EGFR Inhibitor Report Years Considered
Figure 7. Global EGFR Inhibitor Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global EGFR Inhibitor Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by EGFR Inhibitor Revenue in 2023
Figure 10. EGFR Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. First Generation Picture
Figure 12. Second Generation Picture
Figure 13. Three Generations Picture
Figure 14. Four Generations Picture
Figure 15. Global EGFR Inhibitor Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global EGFR Inhibitor Sales Value Market Share by Type, 2023 & 2030
Figure 17. Global EGFR Inhibitor Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 18. Global EGFR Inhibitor Sales Volume Market Share by Type, 2023 & 2030
Figure 19. Global EGFR Inhibitor Price by Type (2019-2030) & (US$/Unit)
Figure 20. Product Picture of Healthcare
Figure 21. Product Picture of Experimental Use
Figure 22. Product Picture of Other
Figure 23. Global EGFR Inhibitor Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global EGFR Inhibitor Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global EGFR Inhibitor Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global EGFR Inhibitor Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global EGFR Inhibitor Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America EGFR Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 29. North America EGFR Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe EGFR Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe EGFR Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific EGFR Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific EGFR Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 34. South America EGFR Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 35. South America EGFR Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa EGFR Inhibitor Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa EGFR Inhibitor Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions EGFR Inhibitor Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions EGFR Inhibitor Sales Volume (%), (2019-2030)
Figure 40. United States EGFR Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States EGFR Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 42. United States EGFR Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe EGFR Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe EGFR Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe EGFR Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 46. China EGFR Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 47. China EGFR Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 48. China EGFR Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan EGFR Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan EGFR Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan EGFR Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea EGFR Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea EGFR Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea EGFR Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia EGFR Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia EGFR Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia EGFR Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 58. India EGFR Inhibitor Sales Value, (2019-2030) & (US$ Million)
Figure 59. India EGFR Inhibitor Sales Value by Type (%), 2023 VS 2030
Figure 60. India EGFR Inhibitor Sales Value by Application (%), 2023 VS 2030
Figure 61. EGFR Inhibitor Industrial Chain
Figure 62. EGFR Inhibitor Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
